ZEKE MILLER Associated Press

WASHINGTON (AP) — Former Trump national security adviser John Bolton said Monday that he is “prepared to testify” if he is subpoenaed by the Senate in its impeachment trial.

Bolton, who left the White House in September, said that he has weighed the issues of executive privilege and that after “careful consideration and study” decided that he would comply with a Senate subpoena.

“I have concluded that, if the Senate issues a subpoena for my testimony, I am prepared to testify," he said in a statement.

Senate Majority Leader Mitch McConnell has publicly expressed resistance to calling new witnesses in the trial, though Democrats are pressing to hear from Bolton and others who did not appear before the House's inquiry in the upcoming proceedings.

Bolton's statement comes as House Speaker Nancy Pelosi is stalling House-passed articles of impeachment against Trump in a bid to get new witnesses to testify. Senate Democratic Leader Chuck Schumer has proposed calling several witnesses, including Bolton, but McConnell has so far rejected Schumer's terms.

It is unclear when Pelosi will eventually release the articles. If she decides to do so in the coming days, a Senate trial could start as soon as this week.

“We can’t hold a trial without the articles,” McConnell tweeted Monday. “The Senate’s own rules don’t provide for that. So, for now, we are content to continue the ordinary business of the Senate while House Democrats continue to flounder. For now.”

Share:
More In Politics
Biden-Putin Square Off for 2 Hours as Ukraine Tensions Mount
Face to face for just over two hours, President Joe Biden and Russia’s Vladimir Putin squared off in a secure video call Tuesday as the U.S. president put Moscow on notice that an invasion of Ukraine would bring enormous harm to the Russian economy.
Pushing COVID-19 Boosters, Biden Says 'We Need to Be Ready'
With rising numbers of COVID-19 cases predicted this winter, President Joe Biden is appealing for Americans to get their boosters and get behind his plan to tackle the new omicron variant through wider availability of vaccines and shots.
Load More